Johnson & Johnson agree deal to sell Lifescan for $2.1 B

Johnson & Johnson agree to a $2.1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. This follows their wrapping up of the insulin pump brand Animas in Q4 of 2017.

Platinum Equity are not new to healthcare having set up SourceOne Healthcare technologies, an imaging products seller, on the back of buying healthcare divisions from Philips and PSS World Medical in 2002.

More at:

https://www.massdevice.com/johnson-johnson-moves-closer-to-exiting-the-diabetes-business-with-2-1b-lifescan-sale/